| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |